Kurin, Inc. Provides Update on Litigation Activity

SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, provides an update to the most recent moves by Magnolia Medical Technologies. This week, Magnolia filed a motion in the US District Court of Delaware for a permanent injunction, hoping to take Kurin off the market. “We are disappointed, but … [Read more…]

Available Now on Amazon Prime Video – the GLAAD Media Award-Winning Filmed Dramatic Reading of NY Times Bestselling Memoir, ‘All Boys Aren’t Blue’ by George M. Johnson Starring Jenifer Lewis, Dyllón Burnside, Bernard David Jones & Thomas Hobson

LOS ANGELES–(BUSINESS WIRE)–The Black Leadership AIDS Crisis Coalition (BLACC) powered by the AIDS Healthcare Foundation (AHF) in partnership with iN-Hale Entertainment and All Tea No Shade Productions announces the Friday, September 16, 2022 Amazon Prime Video premiere of the award-winning filmed dramatic reading of George M. Johnson’s NY Times bestselling memoir, “All Boys Aren’t Blue” … [Read more…]

Hyperice Brings the Heat With Introduction of All-New Venom Go and Venom 2

New Iteration for Heat and Vibration Spot Treatment in Most Portable Adaptation, Products Unveil Revolutionary HyperHeat™ Technology for Fastest Heating Time IRVINE, Calif.–(BUSINESS WIRE)–Hyperice, a global high-performance wellness brand, today announced two new products within their heat therapy category, Venom Go and Venom 2, alongside HyperHeat™ technology for the fastest, most consistent and even distribution … [Read more…]

Certified Professional DNA/Paternity Collector Training Course – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “DNA Specimen Collector” training has been added to ResearchAndMarkets.com’s offering. This course prepares students to conduct buccal swab collections and the accompanying paperwork to be sent to any DNA testing laboratory for testing. Become a Certified Professional DNA/Paternity Collector and help donors learn the truth about their child’s paternity. This is a great … [Read more…]

Lionrock Announces “Stop the Stigma” Theme for 2022 National Online Recovery Day as Overdose Rates Surge

Leading Telehealth Provider of Substance Use Disorder (SUD) Treatment Shares Expert Advice on How to #StopTheStigma at Work for This Year’s Campaign REDWOOD CITY, Calif.–(BUSINESS WIRE)–#NORD–Lionrock, the inventor of online substance use disorders (SUDs) treatment and recovery services in the United States, today announced the theme for the third annual National Online Recovery Day campaign: … [Read more…]

More than one-quarter of Canadians are concerned about their ability to cover basic living expenses

LifeWorks Financial Wellbeing Index™ finds half of Canadians feel the biggest impact of inflation in the cost of groceries TORONTO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its quarterly Financial Wellbeing Index™. The report showed that 29 per cent of Canadians are concerned about their ability to cover basic … [Read more…]

DentalMonitoring Launches DM Insights

DentalMonitoring is Making Industry History with the Launch of DM Insights, the First and Only Clinical Data Analysis Platform to Drive Enhanced Workflows in Dental and Orthodontic Practices PARIS–(BUSINESS WIRE)–DM Insights joins the DM Intelligent Platform, DentalMonitoring’s full suite of solutions designed to improve the quality of care and the patient experience while growing practices … [Read more…]

 Valbiotis Provides an Update on Its Progress and Publishes Its Financial Report for the First Half of 2022

 A cash position of €15.4 million at June 30, 2022. Financial visibility until the last quarter of 2023, excluding potential additional revenues. Continued execution of the strategic and operational roadmap for future commercialization. LA ROCHELLE, France–(BUSINESS WIRE)–Regulatory News: Valbiotis (FR0013254851 – ALVAL / PEA/SME eligible) (Paris:ALVAL), a Research and Development company committed to scientific innovation … [Read more…]

Innate Pharma Reports First Half 2022 Financial Results and Business Update

Monalizumab and IPH5201 developed in collaboration with AstraZeneca advanced into Phase 3 and 2 clinical trials in lung cancer, triggering $55M in milestone payments Second preclinical asset based on Sanofi’s proprietary multifunctional CROSSDILES® platform and Innate’s proprietary multi-specific NK cell engager platform, ANKETTM targeting BCMA, selected by Sanofi for IND-enabling studies, with €3M milestone payment … [Read more…]

Azin Parhizgar To Chair Protembis’ New Board of Directors

Leadership team reinforced for next phase in Protembis’ clinical and regulatory growth trajectory AACHEN, Germany–(BUSINESS WIRE)–#CerebralProtection—Protembis GmbH, a privately-held emerging cardiovascular medical device company, announced today the appointment of highly experienced and successful serial entrepreneur and medical device executive Azin Parhizgar (Ph.D.) as an Independent Member and Chairwoman of the Board of Directors. Azin remains … [Read more…]